Experimental virus injection targets Hard-to-Treat cancers in new trial
Disease control
Recruiting now
This early-stage trial tests a new treatment called T3011, a modified virus injected directly into tumors, for people with advanced solid cancers like melanoma, lung cancer, or sarcoma. The study will also test T3011 combined with the immunotherapy drug pembrolizumab (Keytruda). …
Phase: PHASE1, PHASE2 • Sponsor: ImmVira Pharma Co. Ltd • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC